Nothing Special   »   [go: up one dir, main page]

DK597787D0 - Syntetisk antigen til paavisning af aids-relaterede sygdomme - Google Patents

Syntetisk antigen til paavisning af aids-relaterede sygdomme

Info

Publication number
DK597787D0
DK597787D0 DK597787A DK597787A DK597787D0 DK 597787 D0 DK597787 D0 DK 597787D0 DK 597787 A DK597787 A DK 597787A DK 597787 A DK597787 A DK 597787A DK 597787 D0 DK597787 D0 DK 597787D0
Authority
DK
Denmark
Prior art keywords
related diseases
synthetic antigen
aids
detecting aids
polypeptides
Prior art date
Application number
DK597787A
Other languages
English (en)
Other versions
DK174533B1 (da
DK597787A (da
Inventor
Wesley L Cosand
Linda J Harris
Ray L Houghton
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of DK597787D0 publication Critical patent/DK597787D0/da
Publication of DK597787A publication Critical patent/DK597787A/da
Application granted granted Critical
Publication of DK174533B1 publication Critical patent/DK174533B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16211Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/974Aids related test
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/826Viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/22Viral peptide or viral protein
    • Y10S930/221Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK198705977A 1986-11-14 1987-11-13 Fremgangsmåde til påvisning af antistof mod HIV-virus DK174533B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93078586 1986-11-14
US06/930,785 US5075211A (en) 1986-03-26 1986-11-14 Synthetic antigen for the detection of AIDS-related disease

Publications (3)

Publication Number Publication Date
DK597787D0 true DK597787D0 (da) 1987-11-13
DK597787A DK597787A (da) 1988-05-15
DK174533B1 DK174533B1 (da) 2003-05-12

Family

ID=25459766

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198705977A DK174533B1 (da) 1986-11-14 1987-11-13 Fremgangsmåde til påvisning af antistof mod HIV-virus

Country Status (11)

Country Link
US (1) US5075211A (da)
EP (1) EP0267802B1 (da)
JP (1) JP2886861B2 (da)
AT (1) ATE163766T1 (da)
AU (1) AU616383B2 (da)
CA (1) CA1340097C (da)
DE (1) DE3752170T2 (da)
DK (1) DK174533B1 (da)
ES (1) ES2115584T3 (da)
IE (1) IE81132B1 (da)
NO (1) NO173958C (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273695B1 (en) * 1984-10-31 2007-09-25 Novartis Vaccines And Diagnostics, Inc. HIV immunoassays using synthetic envelope polypeptides
US6210873B1 (en) 1987-08-28 2001-04-03 Board Of Regents, The University Of Texas System Methods and compositions for the priming of specific cytotoxic T-lymphocyte response
US5128319A (en) 1987-08-28 1992-07-07 Board Of Regents, The University Of Texas System Prophylaxis and therapy of acquired immunodeficiency syndrome
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
ZA896768B (en) * 1988-09-09 1990-06-27 Akzo Nv Synthetic polypeptides immunochemically reactive with hiv-antibodies
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
US6589734B1 (en) 1989-07-11 2003-07-08 Gen-Probe Incorporated Detection of HIV
EP0731174B1 (en) * 1989-07-11 2004-11-17 Gen-Probe Incorporated Nucleic acid sequence amplification methods
US5627035A (en) * 1990-08-22 1997-05-06 Syntello Vaccine Development Ab Peptides that block human immunodeficiency virus and methods of use thereof
SE9101863D0 (sv) * 1991-06-13 1991-06-13 Replico Medical Ab Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
JPH06503843A (ja) * 1991-11-04 1994-04-28 デイド、インターナショナル、インコーポレイテッド Hiv−2ウイルスの一部分に対応する合成ペプチドおよび改良されたイムノアッセイにおけるその使用方法
US6165730A (en) * 1992-03-06 2000-12-26 N.V. Innogenetics S.A. Hepatitis C virus peptides obtained from the NS4 coding region and their use in diagnostic assays
US6709828B1 (en) 1992-03-06 2004-03-23 N.V. Innogenetics S.A. Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
US6667387B1 (en) * 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
US6632613B1 (en) * 1993-06-02 2003-10-14 University Of Utah Research Foundation Compositions and kits for fluorescence polarization assay of large molecules
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5603933A (en) * 1993-08-31 1997-02-18 Board Of Regents, The University Of Texas CD4 peptides for binding to viral envelope proteins
CA2177976C (en) * 1993-12-09 2007-12-04 Ai-Ping Wei Compositions and kits for fluorescence polarization assay of large molecules
CA2298438C (en) * 1997-08-01 2010-10-05 Genetic Systems Corporation Synthetic antigen for the detection of antibodies immunoreactive with hiv virus
GB9717652D0 (en) * 1997-08-20 1997-10-22 Nycomed Imaging As Method
EP1131633A2 (en) 1998-11-16 2001-09-12 Board of Regents, The University of Texas System Hiv-specific t-cell induction
JP4824236B2 (ja) * 1999-07-09 2011-11-30 ジェン−プローブ・インコーポレーテッド 核酸増幅によるhiv−1の検出
US6582920B2 (en) 2000-09-01 2003-06-24 Gen-Probe Incorporated Amplification of HIV-1 RT sequences for detection of sequences associated with drug-resistance mutations
KR101933685B1 (ko) * 2018-06-29 2018-12-28 주식회사 에스알바이오텍 약물이 코팅된 마이크로 니들 및 이의 제조방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
GB8324800D0 (en) * 1983-09-15 1983-10-19 Pasteur Institut Antigens
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
IE64006B1 (en) * 1984-10-18 1995-06-28 Pasteur Institut Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
JPS61233700A (ja) * 1984-12-24 1986-10-17 ジエネンテク,インコ−ポレイテツド 分子クロ−ンされたエイズ関連ポリペプチド
WO1986006099A1 (en) * 1985-04-08 1986-10-23 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
EP0220273B2 (en) * 1985-04-29 2007-01-17 Bio-Rad Laboratories, Inc. Synthetic antigens for the detection of aids-related disease
US4661445A (en) * 1985-05-24 1987-04-28 Saxinger W Carl Competitive ELISA for the detection of HTLV-III antibodies
US4704357A (en) * 1985-09-30 1987-11-03 United States Of America As Represented By The Department Of Health And Human Services Immortalized T-lymphocyte cell line for testing HTLV-III inactivation
CS256960B1 (en) * 1985-11-16 1988-04-15 Viktor Krchnak Peptides with properties of antigenic determinants and method of their production
EP0230222A1 (en) * 1986-01-06 1987-07-29 F. Hoffmann-La Roche Ag Expression of HTLV-III gag-Gene
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
JPS63503356A (ja) * 1986-05-20 1988-12-08 ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク ヒトt細胞リンパ球向性ウイルス(htlv‐3)逆転写酵素の発現及びその使用

Also Published As

Publication number Publication date
NO173958B (no) 1993-11-15
JP2886861B2 (ja) 1999-04-26
DE3752170D1 (de) 1998-04-09
EP0267802B1 (en) 1998-03-04
ATE163766T1 (de) 1998-03-15
IE873073L (en) 1988-05-14
EP0267802A2 (en) 1988-05-18
EP0267802A3 (en) 1991-03-06
DK174533B1 (da) 2003-05-12
NO173958C (no) 1994-02-23
IE81132B1 (en) 2000-03-22
CA1340097C (en) 1998-10-20
NO874740L (no) 1988-05-16
US5075211A (en) 1991-12-24
JPS63221247A (ja) 1988-09-14
AU8121187A (en) 1988-05-19
DE3752170T2 (de) 1998-10-08
DK597787A (da) 1988-05-15
AU616383B2 (en) 1991-10-31
NO874740D0 (no) 1987-11-13
ES2115584T3 (es) 1998-07-01

Similar Documents

Publication Publication Date Title
DK626486D0 (da) Syntetiske antigener til afslaering af aids-relateret sygdom
DK597787D0 (da) Syntetisk antigen til paavisning af aids-relaterede sygdomme
ES8708058A1 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
DK643387D0 (da) T-celle-epitoper af hepatitis b-virus-nucleocapsid-protein
EP0280813A3 (en) Synthetic polypeptides and antibodies related to epstein-barr virus early diffuse antigen
ES2101388T3 (es) Antigenos sinteticos para la deteccion de anticuerpos para el virus de la hepatitis c.
PT90574A (pt) Processo de preparacao de polipeptidos e de determinacao da presenca de anticorpos de proteina latente anti-virus do papiloma
ATE87655T1 (de) Markierer der t-zelle aktivierung.
ATE109830T1 (de) Expression von virusproteinen mit immunologischer aktivität.
JPS54126596A (en) Method of detecting or fixing virus antigen or red blood* bacteria antigen or antigen
ATE128716T1 (de) Hiv-peptide und methoden für den nachweis von hiv.
SE8902148L (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE467690T1 (de) Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
ES539638A0 (es) Un procedimiento para analizar una muestra de tejido para determinar la presencia de antigeno de la hepatitis no a no b
DK290887D0 (da) Immunbestemmelse af aterosklerotisk plak-antigen
DK467187D0 (da) Pseudorabiesvirus-vaccine

Legal Events

Date Code Title Description
PUP Patent expired